|
1
|
Prater S and McKeon B: Osteosarcoma.
StatPearls. StatPearls Publishing; Treasure Island, FL: 2022
|
|
2
|
Sadykova LR, Ntekim AI, Muyangwa-Semenova
M, Rutland CS, Jeyapalan JN, Blatt N and Rizvanov AA: Epidemiology
and risk factors of osteosarcoma. Cancer Invest. 38:259–269. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Azevedo JWV, de Medeiros Fernandes TAA,
Fernandes JV Jr, de Azevedo JCV, Lanza DCF, Bezerra CM, Andrade VS,
de Araújo JMG and Fernandes JV: Biology and pathogenesis of human
osteosarcoma. Oncol Lett. 19:1099–1116. 2020.PubMed/NCBI
|
|
4
|
Czarnecka AM, Synoradzki K, Firlej W,
Bartnik E, Sobczuk P, Fiedorowicz M, Grieb P and Rutkowski P:
Molecular biology of osteosarcoma. Cancers (Basel). 12:21302020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen B, Zeng Y, Liu B, Lu G, Xiang Z, Chen
J, Yu Y, Zuo Z, Lin Y and Ma J: Risk factors, prognostic factors,
and nomograms for distant metastasis in patients with newly
diagnosed osteosarcoma: A population-based study. Front Endocrinol
(Lausanne). 12:6720242021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jafari F, Javdansirat S, Sanaie S, Naseri
A, Shamekh A, Rostamzadeh D and Dolati S: Osteosarcoma: A
comprehensive review of management and treatment strategies. Ann
Diagn Pathol. 49:1516542020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smeland S, Bielack SS, Whelan J, Bernstein
M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC,
Anninga J, et al: Survival and prognosis with osteosarcoma:
Outcomes in more than 2000 patients in the EURAMOS-1 (European and
American Osteosarcoma Study) cohort. Eur J Cancer. 109:36–50. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiao B, Liu L, Li A, Xiang C, Wang P, Li H
and Xiao T: Identification and verification of immune-related gene
prognostic signature based on ssGSEA for osteosarcoma. Front Oncol.
10:6076222020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smrke A, Anderson PM, Gulia A, Gennatas S,
Huang PH and Jones RL: Future directions in the treatment of
osteosarcoma. Cells. 10:1722021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng G, Wang J and Huang Y, Lian Y, Chen
D, Wei H, Lin C and Huang Y: Overexpressing CCT6A contributes to
cancer cell growth by affecting the G1-To-S phase transition and
predicts A negative prognosis in hepatocellular carcinoma. Onco
Targets Ther. 12:10427–10439. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang X, Tong Y, Ye W and Chen L: HOXB2
increases the proliferation and invasiveness of colon cancer cells
through the upregulation of CCT6A. Mol Med Rep. 25:1742022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li B, Lu X, Ma C, Sun S, Shu X, Wang Z and
Sun W: Long non-coding RNA NEAT1 promotes human glioma tumor
progression via miR-152-3p/CCT6A pathway. Neurosci Lett.
732:1350862020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng X, Chen G, Lv B and Lv J:
MicroRNA-148a/152 cluster restrains tumor stem cell phenotype of
colon cancer via modulating CCT6A. Anticancer Drugs. 33:e610–e621.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Wang X, Xu L, Lin Y and Zhang J:
CCT6A and CHCHD2 are coamplified with EGFR and associated with the
unfavorable clinical outcomes of lung adenocarcinoma. Dis Markers.
2022:15601992022.PubMed/NCBI
|
|
15
|
He T, Yu D, Wang Z, Guo C, Chang Y and
Wang D: Chaperonin-containing tailless complex polypeptide 1
subunit 6A links with aggravating tumor features and disease-free
survival in surgical gastric cancer patients: A long-term follow-up
study. Clin Res Hepatol Gastroenterol. 46:1019132022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng W, Li W, Zhang X, Cen W and Liu Y:
The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1
expressions and their clinical value in papillary thyroid carcinoma
prognostication. J Clin Lab Anal. 36:e246092022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Volonte D, Sedorovitz M and Galbiati F:
Impaired Cdc20 signaling promotes senescence in normal cells and
apoptosis in non-small cell lung cancer cells. J Biol Chem.
298:1024052022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Greil C, Engelhardt M and Wäsch R: The
role of the APC/C and its coactivators Cdh1 and Cdc20 in cancer
development and therapy. Front Genet. 13:9415652022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ni K and Hong L: Current progress and
perspectives of CDC20 in female reproductive cancers. Curr Mol Med.
23:193–199. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Liu Z, Wu P, Wang H and Ren W:
NUSAP1 Accelerates osteosarcoma cell proliferation and cell cycle
progression via upregulating CDC20 and cyclin A2. Onco Targets
Ther. 14:3443–3454. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Y, Guo C, Fu S, Cheng Y and Song C:
Downregulation of CDC20 suppressed cell proliferation, induced
apoptosis, triggered cell cycle arrest in osteosarcoma cells, and
enhanced chemosensitivity to cisplatin. Neoplasma. 68:382–390.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng W, Wu M, Cheng Y, Liu L, Han Y, Xie
Q, Li J, Wei L, Fang Y, Chen Y, et al: CCT6A knockdown suppresses
osteosarcoma cell growth and Akt pathway activation in vitro. PLoS
One. 17:e02798512022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 106–120. 1980.PubMed/NCBI
|
|
24
|
Qiao S, Qi K, Liu C, Xu C, Ma J, Xu X, Li
C and Wang Z: Long intergenic non-coding RNA 511 correlates with
improved prognosis, and hinders osteosarcoma progression both in
vitro and in vivo. J Clin Lab Anal. 34:e231642020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu MS, Ma QY, Liu DD, Li XJ, Deng LJ, Li
N, Shen J, Zhao Z and Chen JX: CDC20 and its downstream genes:
Potential prognosis factors of osteosarcoma. Int J Clin Oncol.
24:1479–1489. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma J, Yang L, Feng H, Zheng L, Meng H and
Li X: CCT6A may act as a potential biomarker reflecting tumor size,
lymphatic metastasis, FIGO stage, and prognosis in cervical cancer
patients. J Clin Lab Anal. 35:e237932021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huvos AG and Higinbotham NL: Primary
fibrosarcoma of bone. A clinicopathologic study of 130 patients.
Cancer. 35:837–847. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai Y, Wu D and Zhan L: CCT6A expression
in hepatocellular carcinoma and its correlation with clinical
characteristics, liver function indexes, tumor markers and
prognosis. Clin Res Hepatol Gastroenterol. 46:1017962022.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang J, Liu C, Xu G, Liang T, Yu C, Liao
S, Zhang Z, Lu Z, Wang Z, Chen J, et al: CCT6A, a novel prognostic
biomarker for Ewing sarcoma. Medicine (Baltimore). 100:e244842021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang X, Zhang X, Li X, Bao H, Li G, Li N,
Li H and Dou J: Connection between CDC20 expression and
hepatocellular carcinoma prognosis. Med Sci Monit.
27:e9267602021.PubMed/NCBI
|
|
32
|
Gayyed MF, El-Maqsoud NM, Tawfiek ER, El
Gelany SA and Rahman MF: A comprehensive analysis of CDC20
overexpression in common malignant tumors from multiple organs: Its
correlation with tumor grade and stage. Tumour Biol. 37:749–762.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gao Y, Zhang B, Wang Y and Shang G: Cdc20
inhibitor apcin inhibits the growth and invasion of osteosarcoma
cells. Oncol Rep. 40:841–848. 2018.PubMed/NCBI
|
|
34
|
Evenhuis RE, Acem I, Rueten-Budde AJ,
Karis DSA, Fiocco M, Dorleijn DMJ, Speetjens FM, Anninga J,
Gelderblom H and van de Sande MAJ: Survival analysis of 3 different
age groups and prognostic factors among 402 patients with skeletal
high-grade osteosarcoma. Real world data from a single tertiary
sarcoma center. Cancers (Basel). 13:4862021. View Article : Google Scholar : PubMed/NCBI
|
